This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk07: Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Chemers Company fourth quarter 2021 earnings call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again, press star one. Thank you. Jonathan Locke, Senior Vice President and Chief Development Officer, you may begin your conference.
spk02: Jonathan Locke Good morning, and welcome to the Chemours Company's fourth quarter and full year 2021 earnings conference call. I'm joined today by Mark Newman, President and Chief Executive Officer, and Sameer Rahan, Senior Vice President and Chief Financial Officer. Before we start, I'd like to remind you that comments made on this call, as well as the supplemental information provided in our presentation and on our website, contain forward-looking statements that involve risks and uncertainties, including the impact of COVID-19 on our business and operations, and the other risks and uncertainties described in the documents Comoros has filed with the FDC. These forward-looking statements are not guarantees of future performance, and are based on certain assumptions and expectations of future events that may not be realized. Actual results may differ, and Chemours undertakes no duty to update any forward-looking statements as a result of future developments or new information. During the course of this call, management will refer to certain non-GAAP financial measures that we believe are useful to investors evaluating the company's performance. A reconciliation of non-GAAP terms and adjustments are included in our release and at the end of this presentation. With that, I'll turn the call over to our CEO, Mark Newman, who will cover the highlights from the past quarter and full year.
spk08: Mark? Thank you, Jonathan, and thank you for joining us this morning. I will begin my remarks on Chart 3. 2021 was a year where the Chemours team pulled together to deliver strong results quarter after quarter, despite being a year full of challenges. Our performance reflects strong customer demand for our products and our commitment to customer service and supply chain reliability through the toughest conditions, all underpinned by our company-wide commitment to the holistic safety and health of our workforce. Revenue was up 28% year-over-year to $6.3 billion. Adjusted EBITDA rose 49% to $1.3 billion. And we generated $543 million of free cash flow consistent with our focus on sustainable growth and high-quality earnings across our businesses with strong free cash flow conversion. 2021 was truly a team effort across the entire business. In our TT segment, we built what we believe is the strongest book of contracted business ever with strategic customers who appreciate our value proposition and with whom we can grow over time. In TSS, we delivered strong sales and margin performance despite all the OEM headwinds and look forward to the growth we can achieve under the U.S. AIM Act. And in APM, we achieved record-setting results on both the top and bottom line in a business which is being driven by several exciting secular growth trends. Finally, in chemical solutions, we completed the sale of our mining solutions business, which will give us greater bandwidth to focus on our industry-leading TT, TSS, and APM businesses. I'm proud of the results we're reporting today, and proud of the entire Chemours team that delivered them. I would also like to thank our customers for their trust and confidence in Chemours. But 2021 wasn't just about the financial results. We made significant contributions to the planet, our people, and the communities in which we operate through progress on our corporate responsibility commitments. Chemours believes that together with our employees, customers, suppliers, and communities, we will create a better world through the power of our chemistry. Our chemistry is essential to so much of our daily lives today and is also key to a more sustainable infrastructure, clean energy, and advanced electronics. In fact, we are integral to the U.S. semiconductor industry supply chain. And we are making significant investments to manufacture this chemistry responsibly with the latest abatement technology, all part of our commitment to reduce emissions of fluororganic compounds by 99% and greenhouse gas emissions by 60% by 2030. Additionally, we continue to focus on our remediation commitments at our key sites, including the barrier wall project at our Fayetteville, North Carolina plant. Finally, with a DuPont Corteva Chemours MOU behind us, we are actively working to address, manage, and resolve risks to the company related to legacy PFAS liabilities. A good example of this is the resolution of legacy natural resource damage claims in the past year with the state of Delaware. As we look forward to 2022, our guidance reflects our confidence in Chemours and our intent to drive consistent performance through the cycle while generating significant free cash flow. We continue to invest behind key secular growth drivers, especially in clean energy and advanced electronics, and behind innovative and responsible chemistry, that enables the sustainable products of the future, from advanced coatings to low GWP thermal solutions to fuel cells and beyond, all while strengthening our balance sheet and returning the majority of our free cash flow to shareholders. Turning to the next chart, I'd like to highlight more of the good work we're doing across Chemours through our corporate responsibility commitment programs. Last quarter, we discussed our evolved portfolio pillar and how the AMAC will help drive opt-in low GWP refrigerant adoption across the U.S. Today, I'd like to cover our inspired people pillar. The inspired people pillar has been one where we have consistently delivered outstanding progress through all three platforms, safety excellence, vibrant communities, and employee empowerment. In the fourth quarter, we launched a new program we called ChemFest, short for the Chemours Future of Engineering, Science, Trades, and Technology. ChemFest helps bring STEM education to under-resourced middle schools in communities in which we operate. This year, with an initial investment of $4.3 million, We are bringing improved access to early STEM education to schools around our Wilmington headquarters, our New Johnsonville site, and our Chambers Works site. This program is a natural feeder to our FOSSE program, which targets high school seniors pursuing STEM education at the college level. In total, Chemours has committed over $15 million to our Inspired People initiatives, an investment which will pay back many times over in the lives we change and the impact we have on the communities in which we operate. I'm proud of this work, which reflects our company's strong commitment to purpose and people, and would like to thank Alvinia Scarborough, a chief brand officer, and her entire team for leading the charge over the last several years. With that, I'll turn things over to Samir to review the financial results for the fourth quarter. I'll be back to talk about our guidance before turning to Q&A.
spk06: Samir? Thanks, Mark, and thanks, everyone, for joining us today. Before I begin my remarks, I would also like to recognize all our employees for their outstanding effort over the course of 2021. Your energy and determination were instrumental in delivering the outstanding financial results. which Mark and I have the privilege to report. Let me turn to chart five to cover the full-year results. Our 2021 full-year results were driven by strong demand across all three of our primary businesses with a significant rebound in demand from 2020. Full-year net sales rose $1.4 billion to $6.3 billion. Volume and price gains across the portfolio backed by solid operational performance drove the strong results. GAAP EPS more than doubled to $3.60 per share in 2021 from $1.32 per share in 2020. Adjusted EPS was $4 per share in 2021, also more than doubled to $1.98 per share we earned in 2020. Our full year 2021 adjusted EBITDA was $1.313 billion, up $434 million, or 49% from the prior year. This resulted in adjusted EBITDA margins of 21% for the full year, up 300 basis points from 2020. Free cash flow continues to be a strong point for the company. In 2021, we generated $543 million of free cash flow. This is despite the shift to net working capital consumption in 2021 based on improved customer demand and inventory levels. Our performance on free cash flow reflects the power of the business to generate significant cash through any part of the economic cycle and reflects our collective effort to improve the earnings quality of the business since then. Turning to chart six and our fourth quarter results. Fourth quarter net sales of $1.6 billion were up 18% from the fourth quarter 2020. Price gains were strong across the breadth of the portfolio, while volume was up across most of our segments. Adjacent EBITDA rose 25% in the fourth quarter to $307 million, resulting in slight margin expansion to 19% versus 18% in last year's fourth quarter. Pre-cash flow was $131 million, due to higher working capital needed to support increased sales and the impact of certain tax items in the quarter. Turning to chart seven, let's review the adjusted EBITDA bridge for the fourth quarter. Fourth quarter of 2021, adjusted EBITDA was $307 million, up $61 million from the same period in 2020. Price was a large contributor to the improved results, with pricing gains across the entire portfolio. However, the impact of volume gains across most of our segments was more than offset by demand headwinds from automotive OEMs, primarily related to the impact of semiconductor shortages on auto bills. Our net price versus cost contribution continues to be positive. Despite the inflationary environment we are in. As I said in the last quarter, we continue to be diligent across our businesses to ensure that we stay ahead of inflation. Turning now to chart eight, our cash position, liquidity, and balance sheet remain strong, as they have throughout the year. Our cash balance at the end of the year was $1.45 billion, up from $1 billion in the prior quarter. In the fourth quarter, we generated $214 million of operating cash flow, and capex was $83 million. We returned $134 million of cash to shareholders, through dividends and share repurchases. We reduced our debt by $70 million, and proceeds from the mining solution sale were also recognized in the fourth quarter. We ended the year with gross debt of $3.8 billion. Our net leverage ratio improved to 1.8 times on trailing 12-month basis, down from 2.3 times in the prior quarter. Total liquidity stands at approximately $2.3 billion, including revolver availability of approximately $800 million. Turning to chart nine, as we continue to strengthen our cash generation, we also continue to execute on our disciplined approach to capital allocation. In 2021, we invested $277 million in CapEx to maintain our assets, meet our CRC commitments, and grow the business long-term. Timing of our capital expenditures in 2021 was impacted by labor and material issues, which shifted several projects from 2021 into 2022. From a credit profile perspective, we reduced debt by $204 million in 2021, and we also contributed $100 million earlier in the year into the escrow account, as per the MOU agreement with DuPont and Coteva. This amount is reflected restricted cash on a balance sheet. Last but not least, we continue to return the majority of our free cash flow to our shareholders, with $164 million returned via dividends and $173 million through share repurchases in 2021. Since then, we have retired more than 10% of our total shares outstanding. going from approximately 181 million shares to approximately 161 million shares at year-end 2021. Let's now turn to chart 10, where I'll cover the results and outlook for our titanium technology segment. Our titanium technology segment continued to deliver in 2021, with strong performance over the course of the entire year, despite global logistics issues and free stock disruptions. Hyperpigment demand was strong across all regions and all end markets as the global economy recovered from the low levels we saw in 2020. Our previous strategy continues to deliver with strong traction across all three sales channels. Customers continue to see the value of a long-term relationship with Comores as a reliable, high-quality supply has enabled them to succeed despite other supply chain issues. As a result, Our contracted customer base has never been stronger, and we have welcomed many new customers on our flex portal who want to buy Type A upon commerce. Turning to the results, fourth quarter net sales rose 25% to $865 million versus the prior year quarter. Price rose 19%, while volume rose 6% on a year-over-year basis. Fourth quarter adjusted EBITDA of $198 million improved 33% versus the prior year quarter. Segment margins were a healthy 23% despite ongoing over-logistics constraints. The crunch of price of 5% more than offset increased costs in the quarter. For the full year 2021, net sales were $3.4 billion, up 40% from $2.4 billion in 2020. Price rose 10% and volume was up 28% as demand returned from pandemic-induced lows in 2020. Adjusted EBITDA rose 59% to $809 million from $510 million in 2020. Full-year margins came in at 24%. We exited 2021 having regained all of the share lost on installation of our TVA strategy and then some. Price stayed ahead of rising costs throughout the year despite inflationary environment with higher costs required to support type production. Looking ahead, we anticipate strong demand for type of pigment to continue in all geographies and end markets. At the same time, or constraints are likely to continue into the first part of the year, but will moderate over time. As Mark said earlier, we have never felt better about the customer book we have built and look forward to continuing to serve them with the highest quality type of pigment available in the market today. Turning to chart 11, thermal and specialized solutions delivered a strong fourth quarter and full year 2021, driven by improved demand despite headwinds from automotive OEMs related to semiconductor shortages. Our execution throughout the year was solid, and we continue to execute on pricing initiatives to stay ahead of rising raw material costs. The breadth of our portfolio across stationary, aftermarket, and non-refrigerant applications enabled us to deliver solid financial performance, despite the drag of automotive OEM demand headwinds and contractual price downs. Looking more closely at the results, fourth quarter net sales improved 8 percent from the prior year fourth quarter. Strong price contribution in the quarter of 19 percent more than offset the impact of 11 percent lower volumes. As a reminder, the fourth quarter of 2020 was an exceptional quarter from an auto OEM demand perspective, but bills have been down across 2021 due to semiconductor shortages. As a result of these headwinds, adjusted EBITDA declined 8 percent to $97 million in the quarter. For the full year, net sales rose 14 percent to $1.3 billion, the result of stronger volumes and price, which rose 9 percent and 4 percent, respectively. Full-year adjusted EBITDA was $412 million, up 16 percent from $364 million in 2020. Adjusted EBITDA margins improved from 32% to 33%, demonstrating the earnings power of the segment. We delivered solid growth in both legacy refrigerants and low GWP opt-in refrigerants across most end markets. As we look ahead, we expect a continued market recovery in 2022, with recovery in automotive OEM build rates from the semiconductor-related shortages of 2021. The U.S. AIM Act and additional S-gas enforcement in Europe will drive continued conversion to Option low global warming potential solutions. At the same time, we continue to enter new markets with innovative products, including Option 1150, our newest low GWP home blowing agent. Morse remains well positioned to be the sustainable thermal management provider of choice for our customers. Let's now turn to chart 12, for our advanced performance material segment. The APM segment has delivered outstanding results throughout 2021 and exceeded our own expectations for profitability throughout the year. As the business has continued its turnaround, the power of our chemistry continues to shine. From polymers to membranes, the portfolio contains class-leading products which are key to unlocking the future potential of high growth and markets in clean energy, and advanced electronics. Sales had an all-time record of $346 million in the fourth quarter, up 24 percent from $279 million in the prior year fourth quarter. Strong demand drove 10 percent price and 15 percent volume gains on a year-over-year basis, with strong demand underpinning growth across the breadth of the portfolio. Adjusted EBITDA rose 160% to $65 million as price actions and productivity more than offset sharply fired energy and logistics costs in the quarter. For the full year 2021, we delivered record net sales and adjusted EBITDA of $1.4 billion and $261 million, respectively. The top line grew 27% from 2020 levels, with 20% volume growth reflecting strong demand across all product lines. Price growth and currency contributed 4% and 3% respectively to the top line growth. We continue to experience a favorable price-cost dynamic across the diverse product portfolio per segment. And as a result, margins expanded to 19% in 2021 from 11% in 2020. This achievement was exceptional given the logistics and weather-related challenges we experienced during the year. Looking ahead, we believe that strong underlying demand will continue into 2022. We anticipate headwinds from raw material costs, energy, and logistics will moderate over the course of the year. In total, we continue to target top-line growth in excess of GDP. We are also targeting adjusted EBITDA margins in the low 20% with operating discipline and efficient plant operations helping to offset rising input costs. We see significant market momentum building in clean energy and advanced electronics, where our technology is uniquely suited to drive higher levels of performance. Whether it's our NAPIOM members in hydrogen, our Teflon PFA in semiconductor fabs, our Whitecon elastomers in electric vehicles, APM is playing a leading role in enabling the technologies that will help shape the future. Turning to chart 13. we continued to focus the overall portfolio of Comores and completed the sale of our mining solutions business in the fourth quarter. Compatibility of results in the fourth quarter and full year for chemical solution segment was impacted by these portfolio actions. That said, the underlying business performance in PC&I and mining solutions was solid throughout the year. fourth quarter net sales were $69 million, as the impact of price and volume gains of 8% and 14% respectively was more than offset by portfolio changes. Adjusted EBITDA was $8 million in the fourth quarter of 2021, again reflecting the impact of portfolio changes in the quarter. For the full year, net sales were $336 million, while the full year adjusted EBITDA was $51 million. strong demand and pricing gains across the most end markets and key product lines contributed to the solid results. Looking ahead, the segment is now focused on a world-class glycolic asset franchise. We anticipate solid growth in 2022 across both technical and high-purity grades of product, along with continued expansion into new markets such as clean and disinfect and electronics. With that, I'll turn things back over to our CEO, Mark Newman, to cover our 2022 guidance.
spk08: Mark? Thanks, Samir. I'll continue my remarks on chart 14. Our business results have continued to improve steadily and are now well above pre-pandemic levels reported in 2019, a result of the hard work of our employees and execution of our focus strategies. As we look ahead to 2022, We believe our results will continue to improve with another year of solid earnings and cash flow growth. Our full year adjusted EBITDA is projected to be between $1.3 and $1.425 billion, up 8% at the midpoint after accounting for the divestiture of our mining solutions business at the end of last year. We project adjusted EPS of between $4.07 and $4.70. Finally, we forecast free cash flow of greater than $500 million in 2022, inclusive of CapEx of approximately $400 million. Taken together, these results reflect the higher quality business we are driving across Chemours, and our ability to improve earnings through the cycle. From a capital allocation perspective, we remain committed to returning greater than 50% of that free cash flow to our shareholders in the form of dividends and share repurchases. To that end, we expect to complete the remaining portion of our $1 billion share repurchase authorization by mid-2022. With the momentum we have built in 2021, we believe 2022 will be another excellent year for Chemours and for all our stakeholders. I would like to close with some thoughts on the next chapter of Chemours. At Spin, we set out to create a new kind of chemistry company, one which would have the courage to make difficult decisions and lead the industry forward. The foundation which has been laid is strong. As we look to the future, the next chapter of Chemours, Chemours 2.0 as we call it, will refocus our efforts to create a better world through the power of our chemistry. This vision will be underpinned by four key elements. Agile innovation and sustainable solutions, environmental leadership, community impact, and making Chemours the greatest place to work for every employee. To that end, I have challenged every Chemours employee to ensure their work helps to contribute to these goals. I truly believe the spirit of this vision, owned collectively by our 6400 employees, can take the company to new heights. and it will reward our customers, our planet, our team, and, of course, our shareholders. I'm excited to be leading Chemours on this leg of the journey and look forward to engaging with all of you in the coming year. With that, operator, please open the line for Q&A.
spk07: At this time, I would like to remind everyone, in order to ask a question, press star, then the number 1 on your telephone keypad. We'll pause for just a moment to compile the Q&A roster. And your first question comes from the line of John Silverstein from Wolf Research. Your line is open.
spk11: Hey, good morning, guys. For 2022, for TIO2, you're still factoring in continued ore constraints and supply chain issues and raw material inflation. Are you factoring in to get worse relative to the fourth quarter versus, you know, or improvement throughout the course of the year? And if there continues to be ore constraints, what are the supply alternatives for them?
spk08: Hey, good morning, John. Mark here. Our guide really assumes that we continue to build momentum in all three of our industry-leading businesses and And on TIO2 in particular, you know, we were down sequentially in the quarter in line with expectations from a volume perspective on very strong demand. But, you know, as we had indicated in our Q3 call, we were or constrained. And we expect that or constraint to relieve itself in the first half of the year. So we start the year with ore constraint. Our expectation is volumes will be relatively flat from Q4 to Q1. But we'll then, you know, mirror more of the seasonal patterns beyond that as the ore situation resolves itself. So, you know, good quarter on a great year. But I just want to share with you that we see real good momentum in all of our businesses, especially from a demand and a pricing perspective, which we expect to continue.
spk11: Thanks for that. And then just on pricing under the TVS model, you pushed through another 5% increase this quarter on top of a 6% increase in the third quarter. With inflation indicators continuing to push higher and higher, is the expectation for you guys to keep being able to push through higher prices in 2022? Thanks.
spk08: So the short answer is yes. And as you'll see in our EBITDA bridge, you know, we are continuing to be able to take price, you know, across our entire businesses in excess of cost. Clearly, you know, you're going to have some lumpiness as you move through time. So it's not always, you know, perfect timing in terms of how those two move together. But recall that, you know, we have, you know, three go-to markets. approaches on the TBS which provide us real price latitude. Maybe I'll ask Samir to comment on that because that's something that we watch very carefully.
spk06: Thanks, Mark. John, look, you touched on the AVA contract at the same time. In flex and distribution, as Mark talked about, there's an opportunity to push prices even faster than the AVA contracts, right? So all in all, we feel pretty good about where the supply and demand is and what our opportunity is to pass through prices.
spk08: And, Josh, bottom line, I would say, you know, our expectation is to, you know, have our TIO2 business. You know, for the full year, we were at a 24% EBITDA margin. Our expectation on this business is to be in the mid-20s going forward. Clearly, you know, you had a quarter in which we, you know, had lower volumes. related to ore. And as that relieves itself, our expectation is through both price as well as volume, you know, we would return this business to mid-20s going forward.
spk07: Your next question comes from the line of John McNulty from BMO. Your line is open.
spk13: Yeah, thanks very much for taking my question. So a question on the TSS business. Just in terms of how you're thinking about how 2022 plays out, I know we had some of the issues around autos being a little bit weaker in the back half of the year. I assume there's an assumption in your guide for a recovery there. You also had some really strong pricing as well. So I guess, can you speak to how you're thinking about how that business progresses in terms of earnings trajectory through 2022? Yeah.
spk08: Yeah, you know, John, thanks for the question. TSS had a good year despite the auto OEM headwinds, and, of course, we had the winter storm, Yuri, that impacted our Corpus Christi plant early in the year. So when you look at the year of being up 14% with greater than 30% margins with all those headwinds, a really great job by the team. You know, when we look at IHS forecasts, for auto builds. We expect that to be in line with those projections. Clearly, you know, we're focused on both the OEM and aftermarket growth in Optium. And so we feel quite encouraged by that. And our guide reflects, you know, the continuing improvement of the auto as we go through the year. On the pricing side, you know, we're seeing a better market in the stationary, mainly here in North America, but also in Europe. And, you know, as we get through this next COVID wave, you know, our expectation is we'll see a lot more folks, you know, returning to offices, business travel picking up. We'll see a lot more sort of normal recovery. in the commercial aspects of the refrigerant demand across the spectrum. So quite encouraged by early indications in the year, but clearly we have a cautious note in our guidance until the auto OEM situation clears itself.
spk13: Got it, got it. I know that's helpful. And then maybe just as a follow-up, kind of a broader question. So when I look at the guidance that you provided, it's a pretty wide range, admittedly, and look, it's a crazy year to start, so maybe that's part of the rationale. But when I look at the low end of the range, I mean, it's basically pointing to when you adjust for the ChemSol sale, about 1.5% to 2% EBITDA growth, which given kind of the outlook that you laid out for TO2, the outlook that you laid out for TSS, and what I would think is going to be continued decent demand growth in the APM segment, Candidly, I can't figure out what could get you to that low end of the range, so can you kind of help us to at least frame the risks or the potential or the things that could go wrong that maybe put you toward that low end of the range, or is it just, hey, look, it's early and You know, we don't want to set the bar too high type of thing.
spk08: John, I'd say it's early, and we're starting the year, obviously, with a number of uncertainties. We did mention being, you know, or constrained in TIO2. You know, we're seeing, you know, we're not through the SEMICON issue with auto. There's been some auto disruptions even in the court and unrelated to SEMICON. And, you know, so I think it's just, you know, starting the year, you know, with a lot of uncertainty and having some caution in our guidance. But I would not factor anything more into that than this, you know, being thoughtful early on in the year.
spk11: Got it. Thanks very much for the call.
spk08: Thank you.
spk07: Your next question comes from the line of Bob Cort from Goldman Sachs. Your line is open.
spk05: Hey, this is Emily Keck on for Bob. So looking again at the 2022 outlook, it reflects a continued economic recovery, and you guys mentioned the expected supply chain normalization in early 2022. So just kind of across the businesses, what trends have you seen that give you confidence in that normalization?
spk08: Yeah, so, Emily, great question. I would start by saying that demand remains strong. in all key markets and all key product lines and in fact in many cases we are we remain sold out and you know pricing power is in our favor obviously we are working carefully with our customers to make sure we're not doing anything that's disruptive but as i look at it you know clearly uh demand is strong at the outset but we're somewhat constrained, especially in TIO2 as we start the year. So I think our guidance really reflects growth, top-line growth in all of our businesses this year. Clearly, you know, if I go through the businesses, you know, we're, you know, outside of TIO2, you know, we would be looking at the impact, starting the impact of the, you know, AIM Act in our TSS business. where we're going to start to see more traction on some of our blends businesses in refrigerants. Our expectation around our APM business is that's a GDP plus growth from this point on because of all the secular trends related to both Semicon and EVs that are driving our portfolios.
spk05: Okay, great. And then just one more. Can you provide more color on the new strategic partnerships you mentioned in the TNSS business?
spk06: Yeah, Emily, let me just jump in. These are the strategic partnerships we have with the HVAC OEMs. Some of these are public and some are, of course, not in the public domain, but across a broad spectrum of OEM suppliers. We have been working, and as they transition to the new equipment, right, as the AIM regulation comes in, yes, it will be initially the blends portfolio, but all the OEMs are working through their models and upgrading how they will work with the new refrigerant. So there's great, exciting opportunities to be working with our key customers and to help them transition into the new product lines.
spk07: Thank you. Your next question comes from the line of Arun Viswanathan from RBC Capital Markets. Your line is open.
spk09: Great. Thanks for taking my questions. I guess first off, just real quickly on the cash usage, maybe you can just kind of go through and order your priority uses of cash. It looks like you do have quite a bit of cash on the balance sheet there and about close to $1.5 billion, $1.45 billion. but it sounds like your buyback plans are for about $250 in the first half. How do you plan to spend the remainder of the cash there? Thanks.
spk08: So, Arun, great question, and I'll start and ask Samir to follow on as well. So, clearly, when you look at our free cash flow generation in 2021 and the guide that we've given for this year, This will be the third year of free cash flow greater than half a billion. So what we want investors to understand is this is a franchise which has improving earnings quality across all three businesses and significant cash conversion. This is a management team with support from our board that believes in returning the majority of free cash flow to our investors. And in 2021, coming out of COVID-19, we thought a more balanced approach with that in mind made sense. And so you'll see, you know, we made really good gains in terms of improving the strength of our balance sheet and our leverage ratios, as well as returning the majority of free cash flow. We actually stepped up the cash flow to shareholders more so in the second half of last year as we got more confident on the full year outlook. And we're coming into the new year and stepping that up again. So we have $250 million remaining on our current share buyback authorization. And, you know, our commitment is to have that completed in the first half of this year, you know, consistent with the cash generation of the business going forward. Maybe, Samir, I don't know if you have any other thoughts. Thanks, Mark.
spk06: I will just go back to how we kind of talked about the cash usage in the past, right? Look, we as a manufacturer, our first priority in terms of investing in a cash is to make sure we have safe and reliable operations. As you know, we have, you know, our responsibility commitments that we have to ensure we can cut down on the emissions and there's some pretty attractive growth opportunities as well as Mark kind of talked about with But AMAC and all the stuff that's happening around semiconductor, on-shoring, it's a great, exciting opportunity for us both on the APM, TSS, and TT franchises. So our first priority is to make sure we do the right CapEx, and that's why you've seen in the guide roughly 400 million of CapEx. And the way I would look at CapEx, Arun, is, as I said in my remarks, is the number of projects moved from 2021 to 2022. So, combined, the 2021 and 2022 is roughly $350 million of CapEx. And after that, as Mark said, we'll do a little bit of a debt reduction. We are committed to our $3.5 billion gross debt target. We made pretty significant improvement in that. We'll continue to march forward on that. And then, last, is our commitment stays that we will return the majority of the free cash flow to shareholders. So, If you look at our comments around that we expect to finish the remaining commitment on the buyback program in the first half, that's roughly $250 million of cash coming back to the shareholders via repurchases just in the first half of the year. So that's how you should think about our cash usage. Investment, credit profile enhancement, and majority cash coming back to shareholders.
spk09: Okay, thanks for that. And just as a follow up, just I want to understand the high end of the guidance. I know there's about a $60 million difference between the midpoint versus the high end. So would you characterize that as mostly possible that 60 million and APM and TSS if there's quicker resolution on chip shortage issues or supply chain? Is that the right way to think about it? Thanks.
spk06: Yeah, there are lots of puts and takes, but I would say it's pretty balanced. Look, there are growth opportunities across all three businesses, right? If our situation is resolved, I think on the TI side, as Mark said earlier, the demand remains really strong. So there's an opportunity from there, from the midpoint to the high end, And the TSS, you hit the nail on the head. You know, if the auto OEM market recovers, I think that provides us some pretty interesting, exciting opportunities. FCAS regulation, you know, Mark mentioned about AMAC. At the same time, as the enforcement increases in Europe on the FCAS, that provides us an opportunity as well. And similarly, on the APM side, I mean, as we talked about, The margin improvement as the efficiency of the operation improves, getting into the margins in the low 20%, that provides us a great opportunity as well. So it's an opportunity-rich environment across all our three businesses. So on the high end, I would keep it pretty balanced.
spk08: Arun, as I said, we really love the momentum we have in all of our businesses. Obviously, we're being very thoughtful on our guide early in the year. But, you know, when I look at TIO2, we have the best book of business that we've ever had, and we can grow with our customers. We're working to, you know, unlock the bottleneck capacity to achieve that growth. When I look at TSS, you know, we have the recovery of auto plus, you know, the growing impact of AIM over time. as well as just, you know, more commercial refrigeration as, you know, things go back to normal post-COVID. And then in APM, you know, we're working on so many exciting opportunities from Semicon to hydrogen to EVs to advanced electronics, where our fluoropolymers really are the only, you know, are the only answer to sort of solving the world's most difficult issues. So, I'm very excited about, you know, the potential of these three businesses and the focus we have of our leadership team and our employees, you know, to keep driving forward. Thanks.
spk07: Your next question comes from the line of Duffy Fisher from Barclays. Your line is open.
spk13: Yeah, good morning. First question is just around your free cash flow. So last year, you guys did about 41% conversion from EBITDA to free cash flow. At the midpoint this year, that would give you $564 million of free cash flow, which is a pretty big distance. I mean, it's within the guidance, but it's much higher than the $500 million. Is that conversion ratio still good in your mind, or are you likely to convert less EBITDA to free cash flow this year than last year?
spk06: No, it definitely is. I mean, let me just take that one. As you kind of look at the 2022 versus 2021, I think one of the biggest drivers is CapEx, right, as we kind of move from this year to next. As I said, just to our own, you know, CapEx is going up. It's just a transition given how some of the projects got delayed. And also, I think from the working capital perspective, this is a year in which we will be more seasonal in terms of the working capital consumption and release of the working capital. So that's going to have a little bit of impact as well. uh 2019 2022 you know inventories have been pretty light across chain and and that applies to us as well so as we're going to move into 2022 you're going to see some of the working capital stuff as well so all in all i would say you know combination of the two years given the capex movement kind of makes more sense the way you look at it fair enough and then a couple quick ones just on tio2 uh one is you exited last year what percent of your tio2 was on the aba contracts
spk13: And then, two, if you look at the tons you produced last year, where is that relative to your capacity, you know, so we can kind of build in if we think things are going to grow, how many more tons we're going to be able to add over the next couple of years, you know, to your revenue line?
spk08: Yeah. So, Duffy, you know, we've guided to about 70% of our book of business is contracted. and the rest, you know, is either our distributive business or our flex portal. And, you know, we oscillate around that, you know, from quarter to quarter, but that's a pretty good guide. What I tell you is in 2021, you know, our mix of contracted business, you know, really improved. We used the market tightness. as a way to enhance both product and customer mix throughout the year to where we can now say this is, you know, we're supplying, you know, the best set of strategic customers with the best contracts that we've had in our history. So, you know, I'm really encouraged by that. You know, clearly the impact of ore as it relates to capacity is, had an impact on our Q4 volumes, and we're starting the year that way, so we would expect our volumes to be relatively flat from Q4 to Q1. But beyond that, you know, we would expect to be able to show volume growth, you know, as well, given our capacity. Terrific. Thank you, guys. Thanks, Duffy.
spk07: Your next question comes from the line of Vincent Andrews from Morgan Stanley. Your line is open.
spk12: Thank you. Good morning, everyone. Could you just give us a sense of the visibility you have on your supply improving after the first half? And I just ask you, obviously, the situation has gotten more challenging over the last three months, so I'd just like to get a better sense of how much comfort you have in that view on work.
spk08: Yeah, you know, I would say the main thing that we're watching currently is ore supply to TiO2. You know, Vincent, that related to some force majeure activity in Q3 of last year, which, you know, we see improving as we move forward in time. Clearly, even though things at the mine face are improved significantly, you still have the impact of a pretty congested logistics. So, you know, that's really playing into sort of our near-term, you know, performance. But again, our view is, you know, we see that resolving itself here in the first half. And, you know, we'd expect to have more to say at the end of Q1. Okay.
spk12: And just as a follow-up, if I look at your historical balance sheet, and the cash balances at the end of the year. The lowest number I see is 2015's $366 million. Is that, for a walking around assumption, is that sort of an amount that you could comfortably finish the year with on an ongoing basis, or would you need more than that?
spk06: Yeah, so this is Samir. Look, I mean, it really depends on the needs of the businesses and what kind of investments you're looking at, U.S. versus non-U.S. cash. What I would say is the balance sheet cash, you should really look in the context of where we are spending. You know, our... uh you know view is we country will continue to make investments in our businesses um both on the run and maintain reliability perspective and uh you know make continue to make progress on our crc commitments get a balance sheet debt back to three and a half billion dollar kind of a range so we are committed to that and then go back to returning majority of the free cash to the shareholders. So, look, I mean, that's how I would look at it. The exact balance sheet cash, as you know, can move around based on where the needs are and also, really importantly, how we generate the cash into U.S. versus non-U.S. and making sure we have enough U.S. cash.
spk12: Thanks very much.
spk06: Thank you.
spk07: Your next question comes from the line of Josh Spector from UBS. Your line is open.
spk03: Hey, guys, thanks for taking my question. Just a couple ones to pick on Oregon. Just as or limit supply, I guess, is it fair for me to think about most of your North America sales to be on AVAs already? So they get perhaps first dibs at North America supply. And does that mean that Europe gets a bit shorted in the near term, the next couple of quarters? And just on your 2Q seasonal ramp comment, I assume for you to meet that, you need the ore for 2Q already on the water and shipped now. Is that in place to get a 2Q seasonal ramp?
spk08: So I'd say, as I said earlier, the issue at the mine has largely been resolved, and we're seeing improvements there, and shipments are on the water. So, yes, the last question I'd say, the short answer is yes. Obviously, it's something we keep. keep monitoring. Clearly, we are very focused on meeting our contracted book of business and their customer needs first. And when I look at our growth in 2021, You know, we grew in all markets, so there's no sort of North America versus Europe versus AP tradeoff here. The tradeoff is, hey, you make sure you deliver first and protect your contracted book of business, and that's candidly part of the value prop that so many customers have flocked to or are being contracted with Chemours. So in the short term, it will put a little bit more volume as a percentage, you know, on our ABA book. But, again, this is just a matter of a couple quarters here where we're somewhat or constrained.
spk03: Maybe another way to ask that then is, is your flex portal distribution significantly different than your average? I mean, I guess I would think – maybe AP perhaps has more of the spot market activity. Is that a fair way to think about it?
spk08: Our Flex portal is available to our global customers, so customers around the world in different markets. The availability on Flex is somewhat reduced when you're constrained, and then that usually results in prices on Flex, you know, which reflect the spot market, being significantly higher. So, you know, we always want to have volume available for flex and distribution because of the opportunity it brings in a tight market like we have. And that's why, you know, we've made this sort of rule of thumb that we would constrain our contracted book of business to about 70% of our volumes.
spk03: Okay. Thank you.
spk07: You're welcome. Your next question comes from the line of Matthew Dio from Bank of America. Your line is open.
spk01: Morning. Thanks. A few quick ones on the TSS volumes. So if the business was down like 11%, does that mean Option was down closer to 18% to 20%? And why did it take until 4Q to see that headwind, given what we kind of saw transpiring even into 3Q? I know you mentioned comps from last year. Is that the case? Should we see this kind of volume print consistently until we get to the back half of next year, or do things ease up a little bit?
spk08: Now, so I'll start and maybe ask Samir to comment a little bit further. Recall Q4 of last year was a very robust recovery for auto. So it's just a tough year-over-year comp on auto volumes vis-a-vis the Semicron-constrained build and Omicron-constrained build in Q4. So, you know, the way you should read that is just a year-over-year comp. Our expectation, and I think if you look at IHS outlook, you know, they're projecting auto volumes this year to be up around 10%. And so, you know, we're using IHS as the guide. Clearly, you know, we're focused on both OEM and aftermarket opportunities as the opt-in car park continues to build.
spk01: Okay. And then a quick one on PFOA. Okay. So DePont made some comments about making progress on settlement work. They didn't really go into a lot of detail on the call. Maybe that's on purpose. But, you know, there's kind of this outstanding South Carolina MDL and perhaps other cases. I'm just kind of wondering through what the cadence of any kind of announcements we might get through the year, what you're looking at and, you know, how you frame out liabilities versus perhaps risk to setting precedents.
spk08: So, Josh, I wouldn't speculate on cadence, but I'd make two comments here. First is, you know, DuPont, Corteva, and Chemours continue to work well together under the MOU framework, and you saw that this year, you know, with the Delaware settlement that we announced last year. Secondly, you know, as a leadership team, we're always open to potential for settlements that reduce the risk to the company but are done in a way that we believe create value to our shareholders. And so, you know, we will continue to have that mindset. I'm very encouraged by the fact that, you know, in my discussions with DuPont and Carteva, you know, we have a shared view of using the MOU to you know, work through issues that relate to our legacy past. So stay tuned, but nothing more to say at this time.
spk01: Understood. Thanks.
spk07: Your next question comes from the line of Eric Petrie from Citi. Your line is open.
spk10: Hi, good morning, Mark and Samir. Hi, Eric. I saw your second patent infringement case in Japan last And it's a good example of enforcement. But I was wondering, could you give an overview of your patent estate? And when could we expect a competitor to produce an HFO for the auto air conditioning market?
spk08: Hey, we continue to view our patent estate as going well towards the end of this current decade, you know. and we will vigorously defend our IP estate globally. And so I just say we continue to innovate around our Option franchise, bring new IP to market that makes the product better for our customers, and we would expect to continue to have significant IP defenses through later half of this decade.
spk10: Okay. And then secondly, on TIO2, given the shipping and logistics constraints, did you have to reroute any of your TIO2 volumes? I know Altamira is a big exporter of TIO2. So any changes in trade routes?
spk06: Hey, Eric, this is Samir. Nothing of significance. Look, there's always supply chain teams making some adjustments here and there based on the port availability and the vendors that we use, but nothing material.
spk08: Eric, I'll just say, you know, this year our operations teams worked hand-in-glove with procurement and logistics. and our customer service organization to ensure minimal disruption to our customers. And, you know, you don't build a book of business like we have by not really taking seriously your value prop to your customers. So I really, you know, it was a year where we had collaboration across all aspects of the organization. But, you know, a big shout-out to our ops teams who, despite, you know, three waves of COVID, you know, ran our plants really well and worked with our logistics team to make sure our customers had minimal disruptions.
spk09: Thank you.
spk07: Your next question comes from the line of Hassan Ahmed from LMIC Global. Your line is open.
spk00: Morning, Mark. Hi, Hassan. How are you doing? Question around titanium technologies. Look, sequentially, your volumes were down 10%, and I obviously understand the seasonality of things. I understand the sort of supply chain constraint considerations and the like. But one of your sort of larger competitors, you know, back in November had guided to volume decline sequentially in the mid-single digits. So I'm just trying to understand, did you guys lose some market share in Q4 or was that just – you know, the way the market was. And part and parcel with that, on a go-forward basis in 2022, now that you guys stated that you've regained your lost market share, how should we think about your volumes in TIO2 year on year? Will you grow with the market or will you continue to try to regain market share as you consider the bottlenecks and the like?
spk08: Yeah, Hasan, it's a great question. And clearly, you know, among competitors, you will have variation quarter to quarter. But when you look at our overall volumes for the year, you know, TI2 revenue up 40%. You know, it's hard to argue with the result that we had in the year. Samir said in his remarks, we regained the market share we lost with TBS and then some. So, you know, our focus here is to really, you know, maintain our market share, maintain slash grow our market share. But by doing that, by growing with our customers first. You know, we have really a really good strategic book of business, and our focus now is how do we grow as our key strategic customers grow. As it relates to sort of a volume outlook for the year, clearly we're starting the year or constrained. And as I said earlier, we expect that to alleviate itself as we move through the first half. And our expectation is based on the strength of the market we're seeing and how light inventories are throughout the whole system, that we should have another great year in terms of revenue growth in this business.
spk00: understood and as a follow-up just sticking to tio2 again um you know as as you sort of sit there and look at where the cost curves are today um you know with you rightly pointed out or constraints obviously or pricing the prices going up but also sort of the chlorine side of things you know all in out there sort of shuttering as much as 15 percent of uh of their capacity Could 2022 be a year where you see major differences between the integrated TIO2 producers versus the non-integrated ones? And again, you know, I'm thinking about the flexibility that you guys have. in sort of, you know, toggling between a whole range of ores. So could this be a year where the non-integrated, you know, feast or famine, you know, relative to whether you're integrated or not?
spk08: So, listen, we like our booker business. We like our supply on all of our rows. You know, we continue to work, you know, across both chlorine and ore. to be well supplied through time. So, you know, I just say, and then we like our cost curve, where we are on the cost curve. And as we, you know, de-bottleneck capacity, you know, we're seeing opportunities to do that at some of our lower cost plants as well. So overall, you know, Hasan, I remain very encouraged about where we are in our TIO2 journey. Clearly, we're starting the year slightly more constrained, and that's something we'll work our way through.
spk06: Yeah, the only other thing, Hasan, I would add is, look, if you look at the quality of our operations, the technology in TI2, I wouldn't exchange that for anything else. At the end of the day, what matters is return on capital. And with our technology, we believe we have very attractive return on capital in the broader scheme of things. So we take a lot of pride in that. Perfect. Thank you so much. Thanks.
spk07: And there are no further questions at this time. Mr. Mark Newman, I turn the call back over to you for some closing remarks.
spk08: Yeah, thank you. And, listen, we are very excited about the momentum we have in all of our businesses. We're starting the year with very strong customer demand, and our focus this year will be continue to grow earnings. and to throw off significant free cash flow as we grow revenue and earnings going forward. So thank you for your continued interest, and I look forward to speaking to many of you today.
spk07: This concludes today's conference call. Thank you for your participation. You may now disconnect.
Disclaimer